- Estimated deadline
- May 25, 2027
- Expected posting
- Sep 10, 2026
- Award size
- Not listed
- Total program funding
- Not listed
- Expected awards
- Not listed
- Cost sharing
- Not required
- Funding type
- Cooperative agreement
- Category
- Health
Check this solicitation free
Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.
About this opportunity
NINDS intends to support multiple clinical Networks of Diagnostic Excellence (NODEs) as part of the next phase of the Undiagnosed Diseases Network (UDN). Unlike prior phases, clinical NODEs are expected to function as geographically distributed regional clinical networks rather than single-site centers. Each clinical NODE would establish and lead a regional network built on existing partnerships with academic medical centers, hospitals, clinics, federally qualified health centers, and other community-based clinical partners to broaden access to specialized diagnostic expertise and extend the reach of the UDN.
Clinical NODEs are expected to provide a coordinated, multidisciplinary and participant-centered evaluation of individuals with highly challenging, difficult-to-diagnose conditions. In collaboration with the Network, clinical NODEs will recruit and enroll participants, conduct medical record reviews, make enrollment determinations, communicate review outcomes and recommendations to participants and referring providers, and coordinate the clinical evaluation with local partner sites and referring providers, as appropriate.
In addition, clinical NODEs will participate in network collaborations to develop and test innovative, new diagnostic tools and strategies for both genomic and non-genomic conditions, support systematic re-evaluation of unsolved UDN cases, and conduct research to optimize participant access and experience. Clinical NODEs are also expected to participate in network governance and infrastructure; provide training to support consistent implementation of UDN processes and standards; incorporate participant and community input into workflows and engagement strategies, such as through a Community Advisory Board or comparable mechanisms; and monitor site performance.
Applications are not being solicited at this time. This Forecast is being published to provide potential applicants time to plan, establish collaborations, formalize regional partnerships, and prepare responsive projects.
Who can apply
- County governments
- State governments
- Other Native American tribal organizations
- Nonprofits with 501(c)(3) status
- Independent school districts
- Other (see eligibility)
- Federally recognized tribal governments
- Special district governments
- Nonprofits without 501(c)(3) status
- Small businesses
- Private universities
- City or township governments
- Public and Indian housing authorities
- For-profit organizations
- Public and state universities
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
Agency contact
UDN Program Staff
Please contact via email.
- Reads the full solicitation and lays out every required section
- Drafts each section with you, in your words
- Checks the draft against every requirement before you submit
How to write it
All guidesMore from NIH
All NIH funding- Closes in 1 dayRFA-HG-27-011
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
Deadline Oct 30, 2026(1d)Up to $1.3M
- Closes in 1 dayRFA-HG-27-013
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
Deadline Oct 30, 2026(1d)Up to $500K
- Closes in 1 dayRFA-HG-27-012
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
Deadline Oct 30, 2026(1d)Up to $2.3M
- Closes in 1 dayPAR-27-045
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
Deadline Oct 30, 2026(1d)
- Closes in 4 daysPAR-24-280
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline Nov 2, 2026(4d)
- Closes in 4 daysPAR-24-279
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline Nov 2, 2026(4d)
Get new funding every Monday
New federal opportunities and upcoming deadlines for NIH and more, in one short email. Free, unsubscribe anytime.
Details from Grants.gov, last updated Sep 10, 2026. Deadlines and requirements can change: always confirm them in the official notice.